PIM
CHRS icon

Partner Investment Management’s Coherus Oncology CHRS Stock Holding History

Partner Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$68K Sell
3,771
-4,035
-52% -$74.4K 0.49% 39
2019
Q3 		$158K Sell
7,806
-4,801
-38% -$95.9K 0.28% 59
2019
Q2 		$279K Buy
12,607
+4,493
+55% +$78K 0.39% 65
2019
Q1 		$111K Buy
+8,114
New +$108K 0.16% 81
2017
Q3 		– Sell
-24,236
Closed -$348K – 90
2017
Q2 		$348K Buy
24,236
+8,027
+50% +$154K 0.51% 60
2017
Q1 		$343K Buy
+16,209
New +$399K 0.45% 69
2016
Q1 		– Sell
-3,966
Closed -$91K – 81
2015
Q4 		$91K Sell
3,966
-3,065
-44% -$78.9K 0.15% 60
2015
Q3 		$141K Hold
7,031
– – 0.21% 58
2015
Q2 		$203K Buy
+7,031
New +$178K 0.29% 67

Other funds holding CHRS

Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return